Global pharmaceutical company that develops, manufactures, and markets prescription and over-the-counter medications.
Taro Pharmaceutical Industries Ltd., headquartered in Haifa, Israel, is a leading science-based pharmaceutical company that engages in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products across the United States, Canada, Israel, and globally. In addition to its extensive portfolio of finished dosage form products, Taro Pharmaceutical Industries also specializes in the development and manufacturing of active pharmaceutical ingredients used in its formulations.
The company's product offerings span a wide range of therapeutic categories, including but not limited to allergy relief, pain management, antibiotics, cardiovascular health, central nervous system disorders, dermatology, gastrointestinal treatments, and oncology. Taro Pharmaceutical Industries provides these products in various forms such as capsules, creams, drops, injectables, tablets, and topical solutions, among others.
Taro Pharmaceutical Industries distributes its pharmaceuticals directly to wholesalers, retail drug store chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers worldwide. Its customer base includes healthcare institutions and private pharmacies, ensuring broad access to its diverse product lineup.
Founded in 1950, Taro Pharmaceutical Industries has established itself as a trusted provider of high-quality pharmaceuticals, known for its commitment to innovation, stringent quality standards, and customer satisfaction. As a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd., the company continues to expand its global presence and advance its mission of improving patient health through effective and innovative pharmaceutical solutions.